RBC
ZBH icon

Roble Belko & Company’s Zimmer Biomet ZBH Stock Holding History

Roble Belko & Company’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5
Closed -$1K – 344
2017
Q4 		$1K Hold
5
– – ﹤0.01% 311
2017
Q3 		$1K Hold
5
– – ﹤0.01% 281
2017
Q2 		$1K Hold
5
– – ﹤0.01% 288
2017
Q1 		$1K Hold
5
– – ﹤0.01% 335
2016
Q4 		$1K Hold
5
– – ﹤0.01% 354
2016
Q3 		$1K Sell
5
-206
-98% -$25.5K ﹤0.01% 293
2016
Q2 		$25K Buy
211
+206
+4,120% +$23.3K 0.01% 141
2016
Q1 		$1K Hold
5
– – ﹤0.01% 256
2015
Q4 		$1K Buy
+5
New +$489 ﹤0.01% 215

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Roble Belko & Company's ZBH Position: Q1 2018 in Review

Roble Belko & Company sold out of Zimmer Biomet (ZBH) in Q1 2018, closing a stake of 5 shares — an estimated $1K sold.

Roble Belko & Company first reported a position in ZBH in Q4 2015 and held it in 9 quarters. The position peaked at $25K in Q2 2016. 875 funds tracked by Wall St. Rank hold ZBH as of Q1 2018.

  • Roble Belko & Company reported no remaining Zimmer Biomet position as of Q1 2018 after selling out during the quarter.
  • Roble Belko & Company sold 5 Zimmer Biomet shares in Q1 2018, an estimated $1K.
  • Roble Belko & Company first reported a position in Zimmer Biomet in Q4 2015 and held it in 9 quarters.
  • Roble Belko & Company's Zimmer Biomet position peaked at $25K in Q2 2016.
  • 875 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2018.

Based on Roble Belko & Company's 13F filing for Q1 2018, filed 14 May 2018.